Clinical Trials
439
Active:15
Completed:194
Trial Phases
6 Phases
Early Phase 1:2
Phase 1:10
Phase 2:34
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (408 trials with phase data)• Click on a phase to view related trials
Not Applicable
288 (70.6%)Phase 3
38 (9.3%)Phase 4
36 (8.8%)Phase 2
34 (8.3%)Phase 1
10 (2.5%)Early Phase 1
2 (0.5%)Nutritional Intervention for Constipation Symptoms in Patients With Parkinson's Disease
Not Applicable
Not yet recruiting
- Conditions
- Parkinsons Disease (PD)Constipation - Functional
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- Hospital de Clinicas de Porto Alegre
- Target Recruit Count
- 54
- Registration Number
- NCT07213856
- Locations
- 🇧🇷
Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Rio Grande do Sul, Brazil
Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine:On-inferiority Clinical Trial (FIBROSTIM)
Not Applicable
Not yet recruiting
- Conditions
- Fibromyalgia (FM)tDCSDuloxetineBDNFEEG
- Interventions
- Device: Transcranial direct current stimulation (tDCS) plus placebo.Drug: Duloxetine (60 mg) once dailyDevice: Home-based transcranial direct current stimulaiton
- First Posted Date
- 2025-10-02
- Last Posted Date
- 2025-10-02
- Lead Sponsor
- Hospital de Clinicas de Porto Alegre
- Target Recruit Count
- 610
- Registration Number
- NCT07203339
- Locations
- 🇧🇷
Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
Biological and Psychological Markers After Intervention in Adults With GAD
Not Applicable
Completed
- Conditions
- Anxiety
- First Posted Date
- 2025-08-12
- Last Posted Date
- 2025-08-12
- Lead Sponsor
- Hospital de Clinicas de Porto Alegre
- Target Recruit Count
- 36
- Registration Number
- NCT07116980
- Locations
- 🇧🇷
Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil
Triple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to Standard Treatment for Treatment-Resistant Major Depression in the Brazilian Public Health System (SUS)
Not Applicable
Not yet recruiting
- Conditions
- Treatment-Resistant Major Depressive Disorder
- Interventions
- Drug: Normal Saline (0.9% NaCl)
- First Posted Date
- 2025-07-04
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- Hospital de Clinicas de Porto Alegre
- Target Recruit Count
- 32
- Registration Number
- NCT07052058
- Locations
- 🇧🇷
Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
Efficacy of Artificial Intelligence for Gatekeeping in Referrals to Specialized Care
Not Applicable
Not yet recruiting
- Conditions
- Primary CarePrimary Care Patients With Chronic Conditions
- First Posted Date
- 2025-06-13
- Last Posted Date
- 2025-09-15
- Lead Sponsor
- Hospital de Clinicas de Porto Alegre
- Target Recruit Count
- 934
- Registration Number
- NCT07019116
- Prev
- 1
- 2
- 3
- 4
- 5
- 86
- Next
News
No news found